Uganda Preparing for Covid-19 Vaccine Trials

The Uganda Virus Research Institute is partnering with Imperial College London to start the first Covid-19 vaccine trial in the country by December 2020. During the Global Vaccine Summit, hosted virtually by the UK government in June, the WHO welcomed a five-year, U.S.$1.6 billion commitment to Gavi, the Vaccine Alliance, to deliver lifesaving vaccines to the world's poorest countries. There are existing vaccine manufacturing capacities in African countries because some of these countries are involved in the development of vaccines, including yellow fever and Ebola, according Matshidiso Moeti, WHO Africa Regional Director. Uganda has 1,313 confirmed cases of Covid-19 and nine deaths.


AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.